First MPJ Hemi Implants

The BioPro First MPJ Hemi Implant is the globally trusted pre-fusion option for the treatment of hallux rigidus/limitus. BioPro offers the most comprehensive phalangeal based hemi implant system, along with the addition of our new patented HemiEDGE.™

Reproducible results

• On average studies report 95%+ implant survivorship^1-12
• 65+ years of successful, clinical use⁹
• Simple instrumentation

Satisfied patients

• 97% patient satisfaction at 8.3 years¹
• Immediate weight bearing at the discretion of the surgeon
• Return to activity on average 5 weeks faster than fusion patients¹

A trusted pre-fusion option

In the right patient, our implants have been proven to last 20+ years.⁹. If complications do arise, studies show conversion from a failed hallux phalangeal hemiarthroplasty to arthrodesis have similar success rates to primary arthrodesis.¹³

The HemiEDGE™

Potential complications of hemiarthroplasty include implant subsidence, bone overgrowth and implant migration. The HemiEDGE was designed to address these complications by encompassing the proximal phalanx with an overlapping edge around the medial, lateral and dorsal sides. The implant articulating surface remains consistent with the standard design.

Downloads

First MPJ Hemi Brochure 01

Long-Term Results of Hemiarthroplasty Compared With Arthrodesis – Literature Review (2018)

1994 Townley-Taranow Study

HemiEDGE White Paper

HemiEdge Surgical Technique 01

Hemiedge Brochure

Cartiva Revision – Rahimi

A perspective on implant arthroplasty 01

First MPJ Surgical Technique 04